HA-TCP Sponge AMWS-TCP-10

GUDID 00816125023684

HA-TCP Sponge is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone. HA-TCP Sponge is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml.

BERKELEY ADVANCED BIOMATERIALS, LLC

Bone matrix implant, composite
Primary Device ID00816125023684
NIH Device Record Keya7ac64f7-b836-4660-aa4e-92131b41436e
Commercial Distribution StatusIn Commercial Distribution
Brand NameHA-TCP Sponge
Version Model NumberAMWS-TCP-10
Catalog NumberAMWS-TCP-10
Company DUNS081067703
Company NameBERKELEY ADVANCED BIOMATERIALS, LLC
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numbertrue
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS100816125023684 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

MQVFiller, Bone Void, Calcium Compound

Sterilization

Steralize Prior To Usefalse
Device Is Steriletrue

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2020-08-13
Device Publish Date2020-08-05

Devices Manufactured by BERKELEY ADVANCED BIOMATERIALS, LLC

00816125025565 - BiSyntek Granules2025-05-09 Granule Size: 0.5-1mm Volume: 0.5cc BiSyntek Granules is a mixture with a nominal composition of 60% hydroxyapatite and 40% beta
00816125025572 - BiSyntek Granules2025-05-09 Granule Size: 0.5-1mm Volume: 1cc BiSyntek Granules is a mixture with a nominal composition of 60% hydroxyapatite and 40% beta-t
00816125025589 - BiSyntek Granules2025-05-09 Granule Size: 0.5-1mm Volume: 2.5cc BiSyntek Granules is a mixture with a nominal composition of 60% hydroxyapatite and 40% beta
00816125025596 - BiSyntek Granules2025-05-09 Granule Size: 1-3mm Volume: 5cc BiSyntek Granules is a mixture with a nominal composition of 60% hydroxyapatite and 40% beta-tri
00816125025602 - BiSyntek Granules2025-05-09 Granule Size: 1-3mm Volume: 10cc BiSyntek Granules is a mixture with a nominal composition of 60% hydroxyapatite and 40% beta-tr
00816125025619 - BiSyntek Granules2025-05-09 Granule Size: 1-6mm Volume: 15cc BiSyntek Granules is a mixture with a nominal composition of 60% hydroxyapatite and 40% beta-tr
00816125025626 - BiSyntek Granules2025-05-09 Granule Size: 1-6mm Volume: 20cc BiSyntek Granules is a mixture with a nominal composition of 60% hydroxyapatite and 40% beta-tr
00816125025633 - BiSyntek Granules2025-05-09 Granule Size: 1-6mm Volume: 30cc BiSyntek Granules is a mixture with a nominal composition of 60% hydroxyapatite and 40% beta-tr
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.